Will Israel's Teva's new celiac medication be the best thing since sliced bread?
Haaretz
Israeli giant Teva announced positive results in an ongoing study of a new antibody, that protects sufferers of the disease from harm triggered by gluten
More in this section
- New Missouri law forcing schools to target anti-Semitism sparks intense First Amendment concerns
- From a tortured father in Tehran to a brain-cancer cure in Israel: Heshmatpour's two-front fight
- Tehran aims to knock US out of Middle East before renewed attacks on Israel, expert tells ‘Post’
- Senior Israeli official: Settler violence harming Israel, Syria security deal attempt failed